| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | L02BB03 |
| UNII | A0Z3NAU9DP |
| EPA CompTox | DTXSID2022678 |
| InChI Key | LKJPYSCBVHEWIU-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H14F4N2O4S |
| Molecular Weight | 430.38 |
| AlogP | 2.88 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 107.26 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Androgen Receptor antagonist | ANTAGONIST | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 7.4 | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
31-971 | 25-940 | - | 14-509 | 15.5-84 |
|
Protein: Androgen Receptor Description: Androgen receptor Organism : Homo sapiens P10275 ENSG00000169083 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 144093 |
| ChEMBL | CHEMBL409 |
| DrugBank | DB01128 |
| DrugCentral | 367 |
| FDA SRS | A0Z3NAU9DP |
| Human Metabolome Database | HMDB0015260 |
| Guide to Pharmacology | 2863 |
| PDB | 198 |
| PharmGKB | PA164746255 |
| PubChem | 2375 |
| SureChEMBL | SCHEMBL3611 |
| ZINC | ZINC00538564 |